External Validation of the VExUS Score for the Prediction of Acute Renal Failure in Cardiac Surgery
ValiVexus
1 other identifier
observational
119
1 country
1
Brief Summary
Acute renal failure is a frequent complication associated with significant morbidity and mortality in postoperative cardiac surgery. The VExUS (Venous Excess UltraSound grading system) score was created to qualitatively assess this venous congestion, based on ultrasound data from patients obtained post operatively in cardiac surgery. These data included: inferior vena cava diameter, Doppler flow of the suprahepatic veins, portal trunk and renal veins. This score is predictive of the onset of acute renal failure in the first 3 days after surgery. The VExUS score has not been validated in an external and prospective way in cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2022
CompletedFirst Posted
Study publicly available on registry
December 7, 2022
CompletedStudy Start
First participant enrolled
December 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedJanuary 25, 2023
October 1, 2022
1.4 years
October 20, 2022
January 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Association between the change in ultrasound data collected in the VExUS score and postoperative acute renal failure (defined by a creatininemia increase by 26.5 µmol/L in 48 hours).
correlation between operator in term of VExUS staging (VExUS score will be assessed at day 1, 2 and 3 after the surgery, in intensive care unit.
From date of randomization until date of post-operative acute renal failure (detected by daily creatininemia), assessed up to a variable period of time estimated to 2 weeks.
Association between the change in ultrasound data collected in the VExUS score and postoperative acute renal failure.
Specificity of the VExUS score to predict an acute kidney failure will be evaluated
From date of randomization until date of post-operative acute renal failure (detected by daily creatininemia), assessed up to a variable period of time estimated to 2 weeks
Secondary Outcomes (12)
Correlation between the VExUS score and a postoperative acute renal failure
3 days
Diagnostic performances of the VExUS Score for postoperative acute renal failure
3 days
Correlation between central venous pressure (CVP) and postoperative acute renal failure. If a statistical association is present, diagnostic performance (Sensitivity, Specificity, NPV, PPV) of the value
3 days
Correlation between daily fluid balance and postoperative acute renal failure. If a statistical association is present, diagnostic performance (Sensitivity, Specificity, NPV, PPV) of the value
3 days
Correlation between daily fluid balance and postoperative acute renal failure. If a statistical association is present, diagnostic performance (Sensitivity, Specificity, NPV, PPV) of the value
3 days
- +7 more secondary outcomes
Eligibility Criteria
Adult patients scheduled for cardiac surgery will be screened. They will be referred to the preoperative anesthesia consultation by the cardiac surgeons, which is a legal requirement in France. The geographical area of origin corresponds to the recruitment area of the cardiac surgery department of the Grenoble-Alpes University Hospital.
You may qualify if:
- Scheduled cardiac surgery
- Affiliated to a social security system
You may not qualify if:
- Emergency surgery
- Chronic renal failure defined by a glomerular filtration rate of less than 30ml/min or dialysis.
- renal transplant recipients
- Cirrhosis and portal hypertension
- Setting up a left ventricular assist device implantation
- Patient under ECMO (ExtraCorporeal Membrane Oxygenation), intra-aortic balloon pump, or a mechanical circulatory support device such as IMPELLA
- No available operator to perform ultrasound scans
- Patients objecting to the use of their data in research
- Subject under guardianship or subject deprived of freedom
- Pregnant or breastfeeding women
- Resume surgery within 48 hours of scheduled surgery
- Lack of a trained operator to perform D+1 and D+2 ultrasound
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Grenoble
Grenoble, France
Related Publications (4)
Hoste EA, Cruz DN, Davenport A, Mehta RL, Piccinni P, Tetta C, Viscovo G, Ronco C. The epidemiology of cardiac surgery-associated acute kidney injury. Int J Artif Organs. 2008 Feb;31(2):158-65. doi: 10.1177/039139880803100209.
PMID: 18311732BACKGROUNDBeaubien-Souligny W, Benkreira A, Robillard P, Bouabdallaoui N, Chasse M, Desjardins G, Lamarche Y, White M, Bouchard J, Denault A. Alterations in Portal Vein Flow and Intrarenal Venous Flow Are Associated With Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Cohort Study. J Am Heart Assoc. 2018 Oct 2;7(19):e009961. doi: 10.1161/JAHA.118.009961.
PMID: 30371304BACKGROUNDBeaubien-Souligny W, Rola P, Haycock K, Bouchard J, Lamarche Y, Spiegel R, Denault AY. Quantifying systemic congestion with Point-Of-Care ultrasound: development of the venous excess ultrasound grading system. Ultrasound J. 2020 Apr 9;12(1):16. doi: 10.1186/s13089-020-00163-w.
PMID: 32270297BACKGROUNDBossard G, Bourgoin P, Corbeau JJ, Huntzinger J, Beydon L. Early detection of postoperative acute kidney injury by Doppler renal resistive index in cardiac surgery with cardiopulmonary bypass. Br J Anaesth. 2011 Dec;107(6):891-8. doi: 10.1093/bja/aer289. Epub 2011 Sep 22.
PMID: 21940396BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Timothée ABAZIOU, MD
University Hospital, Grenoble
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2022
First Posted
December 7, 2022
Study Start
December 19, 2022
Primary Completion
May 1, 2024
Study Completion
November 1, 2024
Last Updated
January 25, 2023
Record last verified: 2022-10